Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVIVAL: Rimegepant for Vestibular Migraine
NCT06992674Phase 2Active, not recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jun 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rimegepant in vestibular migraine (VM), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Jun 2025; status: active, not recruiting.
02
Drugs
rimegepant
03
Conditions
vestibular migraine (VM)
Beyond the preview
Go deeper on NCT06992674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06992674.